key: cord-0930905-kjc2rtjf
authors: Paolo, Caffarra; Carmelo, Scarpignato; Marcello, Maggio
title: Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy
date: 2020-06-18
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.06.047
sha: 36020afe38510c2b3f6b58ebf1128fd1bcb0fcc0
doc_id: 930905
cord_uid: kjc2rtjf

nan

In Italy the first imported cases were two Chineses, and the first Italian patient of demonstrated severe acute respiratory syndrome (SARS-Cov2) dated February 21st 2020, while in France it started in December (Deslandes A. et al 2020) . Here we present a personal case report of CP, whose hypothetical clinical presentation dated in December 2019. CP is a 68-year-old man academic neurologist, vaccinated against seasonal influenza, mostly vegeterian, with a clinical history of glaucoma, reflux esophagitis and kidney stones, for which he daily assumes brimozidetimolol-brimodinine eye drops and rabeprazol 10 mg. On December 19th cold and soar throat started followed by vomiting and diarrhea which lasted 36 hours. Fever (38.5 °C) without headache began on December 21st and normalized in about 48 hours. At the same time he developed severe arthralgia with moderate movement limitation disappeared about after 3 days during which he took paracetamol 1000 once a day. Marked asthenia begun on December 21st lasting 4 to 5 days. Ageusia without anosmia started on December 26th, lasting about 15 days.

Taste was completely lost and all the food resulted bitter. According to wide clinical spectrum of Covid-19, CP was submitted by MM to the antibody blood test which was available on april 18th. The test, provided by SC, was positive for IgG ( Figure 1 ) which were present in a lesser extent also on June 7h. From December until the lockdown (March 10th) CP had no contacts with people coming from China or subjects with infective respiratory disease.

Although a possible infection cannot be excluded from January to the lockdown, sudden ageusia is uncommon in seasonal influenza and in the present case not related to neurological and systemic diseases or medication, but highly suggestive of SARS-Cov-2 (Lechien et al 2020; Russel et al. 2020 ). For the qualitative detection of IgG and IgM antibodies, we used screen Test Covid-19IgG/IgM2019-nCoV rapid test cassette (Trade name Screen; Whole Blood/Serum/Plasma) a flow chromatographic immunoassay lateral. IgG Relative Sensitivity was 100%, with a specificity of 

SARS-CoV-2 was already spreading in France in late

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say

Conflicts of interest: None to declare. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author contributions:Conception: CP. Data collection: CP, MM and SC.Writing of the first draft: CP.Ethical approval: this letter regards the personal case of Caffarra Paolo (CP), who is one of the authors. CP agrees to describe and share his personal experience among the scientific community and for this reason he decided not to involve the Ethics Committee.